DAPAGLIFLOZIN tablet, film coated [Novadoz Pharmaceuticals LLC]

10 Apr 20264 min read0 viewsVerified Feed

GIST

Updated Date: Fri, 10 Apr 2026 00:00:00 EDT

Clinical Editorial

Summary

DailyMed Drug Label Updates published a clinical update in Pharmacology on 10 Apr 2026. The item focuses on DAPAGLIFLOZIN tablet, film coated [Novadoz Pharmaceuticals LLC]. Open the detail page to review the full original feed content.

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

DailyMedRelated by Drugdapagliflozin

DAPAGLIFLOZIN AND SAXAGLIPTIN tablet, film coated [Novadoz Pharmaceuticals LLC]

Pharmacology • 10 Apr 2026

BMJ OpenRelated by Drugdapagliflozin

Dapagliflozin for cardiorenal protection after intensive care unit discharge: a protocol for a randomised controlled trial evaluating dapagliflozin at ICU discharge for cardiorenal protection (DAPA-ICU)

Research Highlights • 16 Apr 2026

Endocrine NewsRelated by Drugdapagliflozin

Beyond the Scale: GLP-1 Receptor Agonists and Related Incretin Therapies

Research Highlights • 13 Feb 2026

Endocrine NewsRelated by Drugdapagliflozin

Beyond the Scale: What Else Glucagon-like Peptide-1 Receptor Agonists Can Do

Research Highlights • 13 Feb 2026

Feed Metadata

Source

DailyMed Drug Label Updates